Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 5 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
41 48.5 months Nonmetastatic, hormone-refractory prostate cancer 5 Biologic therapy
University of Pittsburgh School of Medicine United States 11/2008
Treatment Details: Patients: This phase 3 study involved 941 patients with non-metastatic, hormone-refractory prostate cancer. These men ranged in age from 47 to 93 years of age. The average time from their
 
42 48.3 months Advanced breast cancer 4 Hormone
Hospital Universitario Arnau de Vilanova Spain 6/2011
Treatment Details: Patients: This study involved postmenopausal women with advanced breast cancer who were divided into 2 separate treatment groups. Group A had 51 patients with a median age of 71.6 years.
 
43 48.2 months Relapsed or refractory B cell lymphoma 4 Immunotherapy
Radiation
Korea Cancer Center Hospital Korea 4/2013
Treatment Details: Patients: This study involved 31 relapsed or refractory B cell non-Hodgkin lymphoma patients. The median patient age was 63 years and 68% were male. Treatment: Patients were given radi
 
44 48.0 months NHL 4 Biologic therapy
Chemotherapy
Hormone
Weill Cornell Medical College United States 4/2014
Treatment Details: Patients: This phase 2 study involved 11 mantle cell lymphoma patients who had not been previously treated. The median patient age was 60 years and 8 were men. Treatment: Patients were
 
45 47.7 months Metastatic breast cancer 5 Hormone
University of California Irvine Medical Center United States 8/2012
Treatment Details: Patients: This study involved postmenopausal women with previously untreated metastatic breast cancer who were divided into two separate treatment groups. Group A consisted of 345 patients
 
46 47.3 months Epithelial ovarian cancer 4 Chemotherapy
Evangelisches Krankenhaus Germany 8/2012
Treatment Details: Patients: This study involved women with epithelial ovarian cancer who had had no prior radiotherpy or chemotherapy. Patients were divided into two separate treatment groups. Group A had
 
47 47.1 months Bladder cancer 5 Chemotherapy
Central Institute of Mental Health Manheim/University of Heidelberg Germany 8/2005
Treatment Details: Patients: This phase III study involved patients with locally advanced bladder cancer who had previously undergone surgery to treat their cancer. Patients were divided into 2 separate trea
 
48 45.0 months Ovarian cancer 4 Chemotherapy
Charite Virchow University Hospital Germany 4/2007
Treatment Details: Patients: This phase II study involved 129 women with epithelial ovarian cancer of FIGO stages II B to IV. The mean age was 59 years, and all had previously undergone surgical treatment.
 
49 44.0 months Bladder 3 Chemotherapy
University of Turin Italy 7/2013
Treatment Details: Patients: This phase 2 study involved 18 patients with carcinoma in situ (CIS) of the bladder. The median patient age was 75 years and 88.8% were male. Treatment: Patients received che
 
50 44.0 months Malignant Pleural Mesothelioma 5 Chemotherapy
Surgery
University of New South Wales Australia 7/2015
Treatment Details: Patients: This study involved 44 diffuse malignant peritoneal mesothelioma patients. The average patient age was 51.6 years and 63.6 were male. Treatment: Patients received cytoreducti
 
Page 5 of 187  | Previous Page  | Next Page